Potency of Orphan Drugs

Orphan drugs are considered to be medicinal products intended for the diagnosis, prevention or the treatment of rare diseases. Approval of all drugs in rare diseases conditions must be based on effectivenessof substantial evidence of effectiveness in treating or preventing the condition with the evidence of safety for the treatment use. Over the last decade of 30 years, more than 400 medicines representing 447 separate medicinal indications have been approved to treat conditions and diseases symptoms rare diseases, compared to lesser than 10 in the 1970s

  • Nonclinical studies
  • Disease Pathophysiology
  • Chemistry, Manufacturing and Control

Related Conference of Potency of Orphan Drugs

May 10-11, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
May 27-28, 2021

7th Rare Diseases and Orphan Drugs

Vienna, Austria
July 19-20, 2021

13th Global Infections Conference

Tokyo, Japan
September 06-07, 2021

11th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany
October 21-22, 2021

International Conference on Tropical Diseases and Cure

Zurich, Switzerland
November 22-23, 2021

3rd World Congress on Advancements in Tuberculosis and Lung Diseases

Singapore City, Singapore
February 07-08, 2022

9th International Congress on Infectious Diseases

Aberdeen, UK

Potency of Orphan Drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in